title: Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast?
authors.forename: Tomonori
authors.initials: T
authors.lastname: Kawasaki
authors.forename: Tetsuo
authors.initials: T
authors.lastname: Kondo
authors.forename: Tadao
authors.initials: T
authors.lastname: Nakazawa
authors.forename: Kunio
authors.initials: K
authors.lastname: Mochizuki
authors.forename: Tetsu
authors.initials: T
authors.lastname: Yamane
authors.forename: Shin-Ichi
authors.initials: S
authors.lastname: Murata
authors.forename: Shingo
authors.initials: S
authors.lastname: Inoue
authors.forename: Hiroko
authors.initials: H
authors.lastname: Tsunoda
authors.forename: Ryohei
authors.initials: R
authors.lastname: Katoh
mesh_terms: D014408:Biomarkers, Tumor / Q000378:metabolism; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D019002:CD56 Antigen / Q000378:metabolism*; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000378:metabolism; D018278:Carcinoma, Neuroendocrine / Q000175:diagnosis* / Q000378:metabolism; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D018300:Papilloma, Intraductal / Q000175:diagnosis* / Q000378:metabolism
chemical_list: D014408:Biomarkers, Tumor; D019002:CD56 Antigen